GROUP ONE TRADING, L.P. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D958. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$285,200
+93.2%
8,000
+150.0%
0.00%
Q2 2023$147,616
-77.3%
3,200
-80.2%
0.00%
-100.0%
Q1 2023$649,620
-16.0%
16,200
-3.0%
0.00%0.0%
Q4 2022$773,711
+9571.4%
16,700
+8250.0%
0.00%
Q3 2022$8,000
-74.2%
200
-50.0%
0.00%
Q2 2020$31,000
-90.3%
400
-94.4%
0.00%
-100.0%
Q1 2020$320,000
+49.5%
7,200
+44.0%
0.00%
+200.0%
Q4 2019$214,000
-6.6%
5,000
+66.7%
0.00%
-50.0%
Q3 2018$229,000
+23.1%
3,000
-25.0%
0.00%
+100.0%
Q4 2017$186,000
-12.7%
4,0000.0%0.00%
-50.0%
Q3 2017$213,000
+56.6%
4,000
+100.0%
0.00%0.0%
Q1 2017$136,000
-85.6%
2,000
-85.1%
0.00%
-77.8%
Q4 2016$942,000
+13357.1%
13,400
+13300.0%
0.01%
Q3 2016$7,000
-97.2%
100
-98.0%
0.00%
-100.0%
Q2 2016$249,000
-66.9%
5,100
-57.1%
0.00%
-72.7%
Q1 2016$753,000
+157.9%
11,900
+357.7%
0.01%
+266.7%
Q4 2015$292,000
-58.5%
2,600
-64.4%
0.00%
-70.0%
Q3 2015$703,000
-46.4%
7,300
-43.0%
0.01%
-44.4%
Q2 2015$1,311,000
+177.8%
12,800
+68.4%
0.02%
+157.1%
Q1 2015$472,000
+11700.0%
7,600
+7500.0%
0.01%
Q4 2014$4,000
-97.5%
100
-96.4%
0.00%
-100.0%
Q3 2014$158,000
+251.1%
2,800
+180.0%
0.00%
+100.0%
Q2 2014$45,0001,0000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 16,200$649,6200.00%
JANE STREET GROUP, LLC 60,000$2,406,0000.00%
SIMPLEX TRADING, LLC 3,200$1280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders